Johnson & Johnson
- SEC CIK
- 0000200406
- Latest filing
- Aug 6, 2026
LYEL holding history
Lyell Immunopharma, Inc. in every 13F filed by Johnson & Johnson, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LYEL overviewAll 13F holders of LYELFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −54,887−100.0% | Sold out | Holders |
| Q4 2025 | 54,887 | $1.69M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 54,887 | $891.4K | 0.2% | +13,722+33.3% | Added | Holders |
| Q2 2025 | 41,165 | $368.0K | 0.1% | 00.0% | UnchangedConverted for a 1-for-20 split | Holders |
| Q1 2025 | 823,317 | $442.9K | 0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 823,317 | $526.9K | 0.1% | +823,317 | New | Holders |